New HealthTech Opportunities in the US: Navigating in the Know
Find the pulse of the US healthcare market and get straightforward, actionable insights to help accelerate commercial traction.
What's it all about?
The US healthcare environment has never seen more change than it has over the last year--posing new opportunities and advantages for healthtech companies entering and expanding their US presence. We'll talk about what's changed, lay out proven strategies for maximizing pilots and partnerships, and a few of the less obvious tactics to accelerate concrete commercial traction.
Leave with actionable concepts, an updated grasp of the US landscape, and warm connections to help your company grow.
__________
Who should attend?
This session will specifically address the opportunities and challenges for both practitioner-driven and consumer medical devices, digital health, and diagnostics. For pharma, please contact us directly for insights.
◈ Entrepreneurs and commercial leaders with a ready-to-scale healthtech product who need to accelerate time-to-market while managing cost-of-entry
◈ Life science innovators exploring potential US partnerships--many accelerators, corporate ventures, and distributors we mention work across biotech and cleantech
◈ Scaleups running lean and evaluating nimble ways to climb the value chain in our fragmented, complex, and opaque healthcare ecosystem
__________
➩10:00 AM - 10:30 AM: Keynote with straightforward answers and insights
➩10:30 AM - 11:00 AM: Roundtable conversation with corporate and startup perspectives
__________
Roundtable
◈ Elizabeth Jennings | Principal, Venture Atlas Labs & Board of Directors, SWAN Impact Network
◈ Don Fowler | Principal, Venture Atlas Labs; Private Equity advisor; former CEO of Toshiba Medical
◈ Harris Eyre | Author, brain health executive, and diplomat at the OECD - OCDE; Co-Founder of PRODEO Institute
__________
Want to submit a question?
✉ Drop the host an email at elizabeth@ventureatlaslabs.com --or join the live chat for Q&A.
Speakers
Elizabeth Jennings leads US-based Venture Atlas Labs for healthcare commercialization and serves on the Board of Directors for SWAN Impact Network and the Texas Global Health Security Innovation Consortium. She is a frequent global speaker, practical advisor, and renowned palliative gardener.
Schedule
Join this keynote to learn about emerging opportunities, get case studies to frame your thinking, and leave better equipped to prioritize your efforts.
Jump into conversation with this panel of US healthcare decision-makers from leading institutions to hear how their priorities are influencing new technology adoption, what new regulatory policies have impacted their budgets, and how they engage with Value Analysis Committees and multiple purchasing organizations to work with international technologies.
Come prepared with questions, as this will be an opportunity to ask and engage with our leaders.
Book now
Brought to you by
